Identification and Deletion of Sequences Required for Feline Leukemia Virus RNA Packaging and Construction of a High-Titer Feline Leukemia Virus Packaging Cell Line  by Burns, Cara Carthel et al.
VIROLOGY 222, 14–20 (1996)
ARTICLE NO. 0393
Identification and Deletion of Sequences Required for Feline Leukemia Virus RNA Packaging
and Construction of a High-Titer Feline Leukemia Virus Packaging Cell Line
CARA CARTHEL BURNS, MARIA MOSER, JENNIFER BANKS, JOHN P. ALDERETE, and JULIE OVERBAUGH1
Department of Microbiology, University of Washington, Seattle, Washington 98195
Received March 6, 1996; accepted June 5, 1996
Sequences required for specific encapsidation of feline leukemia virus (FeLV) genomic RNA have not yet been defined.
Deletion of 107 nucleotides between the splice donor (SD) and the gag coding region of a prototypic subgroup A FeLV,
61E, resulted in an approximately 200-fold reduction of packaged viral RNA. Virus particle production was not disrupted by
the deletion, although viral infectivity was dramatically reduced. These data indicate that the 107-nucleotide sequence
comprises a portion of the FeLV packaging signal. FeLV particles expressed from the deleted genome were able to efficiently
package murine leukemia virus vectors, resulting in high-titer G418R virus production. This system can be easily adapted
to produce FeLV particles that contain envelope proteins from other feline leukemia virus subgroups and will be broadly
useful for studies of FeLV envelope/receptor interactions. q 1996 Academic Press, Inc.
INTRODUCTION FeLV shares RNA sequence and secondary structure
similarities with MuLV C (Fig. 1; Konings et al., 1992).
Retrovirus particles contain two molecules of genomic
For example, the prototypic replication-competent FeLV-
RNA noncovalently joined at their 5* ends. Incorporation
61E (Overbaugh et al., 1988) shows 70% identity in the
of full-length genomic retroviral RNA into virus particles
region between the splice donor and coding sequences
is directed by specific viral sequences, which are recog-
for the glycosylated gag protein (excluding gaps). These
nized by viral protein(s) encoded by the gag gene (re-
included sequences that could potentially form two
viewed in Linial and Miller, 1990). Viral RNA packaging
stem–loop structures thought to be important for recog-
requires that viral proteins discriminate between geno-
nition of C in MuLV and spleen necrosis virus (SNV)
mic viral RNA, subgenomic viral RNA, and cellular RNA,
(Yang and Temin, 1994; Fig. 1B). In order to avoid dis-
all of which are generally similar in structure and have
rupting sequences important for protein expression, we
a 5* m7G cap and 3* poly(A) tail (Coffin, 1985, 1984).
chose to focus on this region to identify sequences im-
Although the precise mechanisms that regulate specific
portant for RNA encapsidation and to establish a FeLV
encapsidation are not well understood, cis-acting se-
packaging cell line.
quences that are required for viral RNA packaging (C
sequences) have been defined for several retroviruses.
MATERIALS AND METHODSFor example, a 286- to 351-bp sequence between the
splice donor (SD) and gag in murine leukemia virus
Plasmid constructions and mutagenesis
(MuLV) was determined to be critical for viral RNA pack-
aging because its deletion reduced the amount of viral The plasmid p61E encodes a replication-competent
RNA packaged by at least 100-fold (Mann et al., 1983; virus and has been described previously (Overbaugh et
Sorge et al., 1984). Later studies provided indirect evi- al., 1988). The plasmid p61E-DC was constructed by the
dence that the sequences essential for Moloney MuLV following procedure: Overlap extension PCR (Ho et al.,
(MoMuLV) packaging were contained in the 5* half of this 1989) was used to make a 107-nt deletion that starts 13
sequence (Schwartzberg et al., 1983). Other experiments nt downstream of the splice donor and ends 21 nt up-
have shown that a longer MuLV sequence is required stream of the AUG initiation codon for the glycosylated
for optimal RNA packaging (Adam and Miller, 1988; Arm- polyprotein gPr80gag (Donahue et al., 1988; in bold print
entano et al., 1987; Bender et al., 1987). in Fig. 1). The deletion was amplified in the context of a
The sequences required for encapsidation of genomic 1.1-kb PCR fragment spanning the entire LTR starting
RNA of FeLV have not yet been defined, and this has with an added EcoRI site and part of the gag gene (nt 1
hindered the construction of FeLV packaging cell lines. to 1159 in FeLV-61E, GenBank No. M18247). The PCR
fragment containing the deletion was subcloned into the
plasmid p5* 61E-3061 (which encodes the 5* segment of1 To whom correspondence and reprint requests should be ad-
dressed. Fax: (206) 543-8297. E-mail: overbaug@u.washington.edu. 61E, from nt 1 to the NcoI site at nt 3061 in the pol gene
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in pUC18) using an EcoRI site in the polylinker and a G418 (60% active drug; Gibco/BRL, Grand Island, NY) per
milliliter for 2 to 3 weeks, and single-cell clones wereBgl II site at 1106. The plasmid containing the 107-nt
deletion is called p5* 61E-DC. To verify that the desired isolated. Cell clones that produced the highest amounts
of virus particles were chosen by determining the G418Rchanges were present, the PCR-amplified portion of the
genome was sequenced using the Sanger dideoxy chain virus titers of the cell-free culture supernatant from each
cell line using standard methods (Miller and Rosman,termination method (Sanger et al., 1977). A 61E genome
containing the 5* deletion was reconstructed by ligating 1989).
two fragments: (1) a Bgl II-Sal I fragment of p5* 61E-DC
Analysis of viral proteinsthat included the pUC plasmid as well as sequences
from the deletion construct between FeLV-61E nt 1 and Radioimmunoprecitation analysis (RIPA) was per-
1106 and (2) the Bgl II– Sal I 61E fragment encompassing formed as described previously (Burns et al., 1995). FeLV
nt 1107 to nt 8443 of FeLV 61E plus cellular flanking proteins were immunoprecipitated from the culture su-
sequences. This plasmid is referred to as p61E-DC. pernatant of cells labeled with [35S]methionine and [35S]-
The plasmids pLXSN and pLAPSN have been de- cysteine for 22 hr (Burns et al., 1995) using a polyclonal
scribed previously (Miller and Rosman, 1989; Miller et anti-FeLV antiserum (77S000301) that recognizes gag
al., 1994). The LXSN vector encodes a murine sarcoma and env proteins (Burns et al., 1995).
virus (MuSV) LTR and MuSV/MuLV C sequences, as well
as neomycin phosphotransferase, a protein that confers Analysis of viral RNA
resistance to the drug G418, which is expressed under
Total cellular RNA was prepared from cells using thethe control of the SV40 promoter (Miller and Rosman,
guandidinium isothiocyanate method (Chomczynski and1989); LAPSN encodes alkaline phosphatase in the multi-
Sacchi, 1987). RNA was prepared from purified virus asple cloning site of LXSN (Miller et al., 1994) downstream
described previously (Aronoff and Linial, 1991). Briefly,of C, under the control of the LTR.
cell culture supernatants were clarified by low-speed
centrifugation. Virus particles were purified by ultracen-
Transfection and isolation of stable cell lines trifugation through a 20% sucrose cushion. RNA was iso-
lated by phenol/chloroform extraction and ethanol pre-The plasmid p61E-DC was introduced into the D17
cipitation in the presence of 20 mg carrier tRNA andcanine osteosarcoma cell line along with DNA encoding
subsequently analyzed by Northern blot analysis usingresistance to the drug hygromycin (CMVhph; Aronoff and
the gpStu probe.Linial, 1991) by calcium phosphate cotransfection (Chen
For RT-PCR analysis, virus particles were prepared asand Okayama, 1987). Cell clones expressing CMVhph
described for Northern blot analysis. After the precipita-were selected in 155 units hygromycin B (Calbiochem,
tion step, RNA was subjected to DNase I treatment (0.1San Diego, CA) per milliliter for 2 to 3 weeks. To deter-
unit per microliter) in the presence of 5 mM MgCl2 . Viralmine if the clones also encoded 61E-DC sequences,
RNA was extracted from virus particles using Isoquickstable hygromycinR cell lines were screened for FeLV
(Microprobe, Bothell, WA), followed by ethanol precipita-gag expression by a FeLV p27gag-specific enzyme-linked
tion using 20 mg glycogen as carrier. Purified RNA wasimmunosorbent assay (ELISA; Virachek/FeLV, Synbio-
serially diluted, and the diluted RNA samples were con-tics, San Diego, CA). FeLV gag-positive cell lines were
verted to cDNA using random hexamer primers and theanalyzed by Southern and Northern blot analysis using
Moloney MuLV RT Superscript II (Gibco/BRL, Grand Is-a probe (exU3) that hybridizes to an exogenous FeLV-
land, NY), according to the manufacturer’s conditions.specific long terminal repeat (LTR) (Mullins et al., 1986)
The cDNA was amplified by PCR using primers spanningor a probe (gpStu) that hybridizes to sequences in the
235 nt in the U3 region of the LTR (U3-1 and U3-2B) asgag and pol genes (StuI fragment, nt 2093 to 4818). Cell
described previously (Rohn and Overbaugh, 1995).lines that expressed full-length and subgenomic RNAs
were further screened for virus production by reverse
Virus infection
transcriptase (RT) assay of cell-free supernatants (Goff
et al., 1981) to identify cell clones expressing higher lev- The ability of 61E-DC to replicate and spread in cul-
ture was determined by infecting feline 3201 T cells withels of viral proteins.
Stable cell lines expressing both 61E-DC and the up to 1 ml of virus supernatant as described previously
(Thomas and Overbaugh, 1993). Cells were examined forLAPSN vector were made by infecting D17-61E-DC cell
lines with virus from the PG13 packaging cell line (Miller evidence of virus replication by p27gag ELISA over a 7-
week period.et al., 1991) that harbors the LAPSN vector. The PG13
cell line expresses the envelope protein from gibbon ape As a more sensitive test for infectious virus in the D17-
61E-DC cell line, we used a marker rescue assay, whichleukemia virus, which allows infection of cells of many
species, including feline cells. After infection with PG13 is similar to an assay (Miller and Rosman, 1989) that
has been used to analyze packaging cell lines for thevirus, cells were selected in medium containing 0.8 mg
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production of replication-competent helper virus. Various virus particles, FeLV proteins were immunoprecipitated
from the culture supernatant of 35S-radiolabeled cells.amounts of virus from the D17-61E-DC packaging cell
line (1 ml to 1 ml) or the 61E control (0.002 to 2 ml) The mature FeLV proteins gp70 (SU), p27gag (CA), and
p15gag (MA) were detected in immunoprecipitates usingwere added to 3201 cells expressing LAPSN, and these
infected cells were maintained for 3 weeks with passage. a polyclonal anti-FeLV antiserum that recognizes gag
and env proteins (Fig. 2, lane 2). The pattern of immuno-To detect the presence of infectious FeLV that had pack-
aged LAPSN, culture supernatants from the infected cells precipitated proteins was similar to that produced by
the subgroup B FeLV molecular clone EEZZ, which waswere filtered and used for infection of feline AH927 cells
in the presence of 4 mg polybrene per milliliter. At 2 days chosen for comparison because it, unlike FeLV-61E, in-
fects and replicates in D17 cells (Boomer et al., 1994; Fig.postinfection, the infected AH927 cells were fixed and
stained to assay for alkaline phosphatase activity (Fields- 2, lane 3). As expected, based on amino acid sequence
comparisons, the D17-61E-DC gp70 envelope proteinBerry et al., 1992), which would indicate the presence of
helper virus that had transferred the LAPSN vector from migrated with a slightly reduced mobility compared to
EEZZ gp70. Figure 2 shows that the ratio of gag to envthe 3201 cells to the AH927 cells.
The virus titers produced from single-cell clones ex- proteins appears to be somewhat lower for this D17-61E-
DC cell line than for EEZZ. We have not analyzed thispressing both FeLV 61E-DC and the LAPSN vector were
determined by infecting AH927 cells with supernatant in careful detail because large amounts of virus particles
are produced (see below). The pattern of immunoprecipi-from cell clones using standard methods (Miller and Ros-
man, 1989). tated proteins in the culture supernatant of 61E-infected
AH927 cells was similar to that of D17-EEZZ (data not
shown). Therefore, the 107-nt deletion or single-aminoRESULTS
acid mutation may have a modest effect on viral protein
Deletion of putative C sequences in FeLV expression but does not significantly impair expression
proviral DNA and processing of viral proteins.
In order to study the role of specific sequences in
Viral RNA packagingthe 5* nontranslated region in viral RNA packaging, we
constructed a full-length FeLV 61E genome (61E-DC)
To test whether the deletion in D17-61E-DC affectedcontaining an 107-nt deletion between the splice donor
RNA packaging, we examined virus particles for the pres-and the AUG initiation codon for the glycosylated poly-
ence of viral RNA. Genomic RNA was detected by North-protein gPr80gag (Donahue et al., 1988; in bold print in Fig.
ern blot of total cellular RNA from D17-61E-DC-express-1). Sequence analysis of the amplified region showed the
ing cells (Fig. 3A, lane 2) and in AH927 feline fibroblastpredicted deletion, as well as a silent mutation and a
cells chronically infected with subgroup A FeLV 61E (Fig.valine-to-alanine substitution at amino acid 17 of the gly-
3A, lane 3), although the amount of viral RNA in D17-cosylated gPr80gag polyprotein. The glycosylated gag pro-
61E-DC cells was 4-fold lower than in 61E-infected cellstein is encoded in both the FeLV [initiated at AUG346 ;
(as determined by phosphoimaging analysis; not shown).Laprevotte et al., 1984] and the MuLV (Shinnick et al.,
When viral RNA extracted from virus pellets was analyzed1981) genomes [initiated at CUG359 ; Prats et al., 1989]
by Northern blot, full-length viral RNA was detected in 1and is expressed in infected cells (Edwards and Fan,
ml, 100 ml, and 50 ml of culture supernatant of 61E-in-1980; Neil et al., 1980). However, it is unlikely that the
fected AH927 cells (Fig. 3B, lanes 3, 5, and 8), whereasvaline-to-alanine substitution in 61E-DC would affect vi-
viral RNA was not detected in as much as 20 ml of cultureral expression, because gPr80gag is not required for repli-
supernatant from D17-61E-DC cell line (Fig. 3B, lanecation in tissue culture cells, at least in the case of MuLV,
2). Upon longer exposure, RNA from 10 ml of culturewhere this has been studied (Mann et al., 1983; Prats et
supernatant of 61E-infected cells was detected, whereasal., 1989; Schwartzberg et al., 1983).
RNA was still not detected in 20 ml D17-61E-DC (data
not shown). Our inability to detect RNA in D17-61E-DCAnalysis of viral protein expression in cells
did not reflect the loss of small amounts of virus particlesexpressing 61E-DC
because we were able to detect viral RNA from 61E
culture supernatant diluted 10-fold (lanes 4 and 6) or 100-The plasmid encoding full-length 61E-DC was intro-
duced into D17 cells to produce stable cell lines. We fold (lane 7) with medium before ultracentrifugation. This
2000-fold difference in the volume of culture supernatantused a canine cell line, rather than a feline cell line, to
avoid recombination between endogenous FeLV se- required to generate a positive signal indicates that viral
RNA packaging is disrupted significantly by the 107-ntquences and exogenous FeLV, which could form replica-
tion-competent virus. To determine if the deletion and/or deletion. After normalizing samples for the number of
virus particles by assaying for RT activity, the amount ofthe single amino acid substitution in gPr80gag in 61E-
DC affected viral protein expression or the production of viral RNA packaged in D17-61E-DC virions was at least
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FIG. 1. (A) Alignment of FeLV and MuLV RNA sequences in the region encompassing the 107-nt deletion. At the top, a schematic diagram of the
FeLV genome is shown to provide orientation. The sequences shown are of FeLV-61E (Donahue et al., 1988; Overbaugh et al., 1988) and Moloney
MuLV (Shinnick et al., 1981), numbering from nucleotide 1 in the R region of the LTR. The translational start codons for the FeLV glycosylated
gPr80gag protein (AUG346) and the MuLV glycosylated gPr80gag protein (CUG359) are depicted in bold print. For FeLV and MuLV, the downstream
start codons (AUG568 and AUG623 , respectively) depicted in bold print are the sites of initiation of translation of the Pr65gag protein, the precursor
for mature matrix, capsid, and nucleocapsid proteins. The box denotes the 107-nt FeLV deletion, which is located between the splice donor site
(indicated by an arrow) and the start codon for translation of gPr80gag. The 351-nt MuLV C region, as originally defined by Mann et al. (1983), is
underlined. The GACG sequences in the hairpin motif (HPM) are printed in bold type, and the splice donor for the envelope mRNA is indicated by
an arrow. Dashes indicate gaps in the aligned sequences. (B) Secondary structure model of FeLV packaging sequences. Predicted secondary
structure of FeLV-61E in the region of the 107-nt deletion is based specifically on the models of Konings et al. (1992) and Yang and Temin (1994).
Items are labeled as described for A.
250-fold lower than in 61E virions. Similar results were normalizing for the number of virus particles by RT assay,
the amount of viral RNA packaged in D17-61E-DC virionsobtained with three other stable cell lines expressing the
was approximately 180-fold lower than in 61E virions.DC FeLV provirus (data not shown).
These experiments confirm the results obtained usingTo complement Northern analyses, viral RNA was also
Northern blot analysis, but suggest that there are veryanalyzed by RT-PCR, which is more sensitive but does
small amounts of FeLV RNA in particles expressed fromnot discriminate between partially degraded RNAs and
the C-deleted genome.full-length RNA. RT-PCR was performed using purified
viral RNA as the template for cDNA synthesis, followed
Viral infectivity and marker rescue assayby PCR amplification. Using an RT-PCR method specific
for FeLV U3 sequences, product was detected in reac- In infection studies using up to 1 ml of D17-61E-DC
tions using RNA from as little as 0.02 ml 61E culture cell culture supernatant, we could not detect evidence
supernatant, whereas FeLV RNA could only be detected of virus replication by p27gag ELISA over a 7-week period
in D17-61E-DC virus when there was the equivalent of in a susceptible feline cell line, 3201 T cells. In contrast,
we typically detect 104 –105 infectious virus particles per20 ml or more of supernatant (data not shown). After
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suggest that very little or no replication-competent virus
is produced in D17-61E-DC cells.
Production of high-titer replication-defective
G418R virus
Because FeLV can package MuLV vectors, we could
use these vectors to demonstrate that the virions pro-
duced from D17-61E-DC were capable of transferring
retroviral vector RNA. The virus titers produced from sin-
gle-cell clones expressing both D17-61E-DC and the
LAPSN vector were determined by infecting AH927 cells.
From some cell clones, we detected up to 4 1 106 G418R
cfu/ml, which is similar to the G418R cfu/ml obtained for
wild-type 61E virus carrying LXSN (data not shown).
These high virus titers demonstrate that the virus parti-
cles produced from the C-deleted FeLV genome were
FIG. 2. Immunoprecipitation of viral proteins from D17 canine cells
expressing FeLV proteins. D17 cells were labeled with [35S]methionine
plus [35S]cysteine for 22 hr, clarified cell-free supernatants from an
equal number of cells were immunoprecipitated with anti-FeLV anti-
body, and precipitated proteins were analyzed by SDS–12.5% PAGE.
The viral genome expressed in each cell line is indicated above each
lane. The viral proteins gp70 (SU), p27gag (CA), and p15gag (MA) are
indicated with an arrow.
milliliter in supernatants from 61E-infected cells (data not
shown). As a more sensitive test for infectious virus in
the D17-61E-DC cell line, we used a marker rescue
assay, which is designed to detect the production of
replication-competent helper virus and low levels of in-
fectious virus particles that have packaged C-deleted
genomic RNA. Previous experiments in our lab and the
labs of others (Takeuchi et al., 1992; J. Abkowitz, personal
communication; see below) had established that wild-
type FeLV was able to efficiently package murine retrovi-
ral vectors, such as LXSN, which encodes G418 drug
resistance, or its derivative LAPSN, which encodes G418
drug resistance and alkaline phosphatase. As shown in
Fig. 4, various amounts of virus from the D17-61E-DC
packaging cell line or the wild-type 61E control were
added to 3201 cells expressing LAPSN, and these in-
fected cells were maintained for 3 weeks with passage.
FIG. 3. Northern blot analysis of RNA present in virus particles andIn order to detect helper virus, culture supernatants from
cells expressing FeLV genomes. RNA was electrophoresed through athe infected cells were used for infection of feline AH927
1% agarose–formaldehyde gel, followed by Northern blot analysis us-cells and subsequent assay for alkaline phosphatase
ing the anti-gag/pol probe gpStu. The viral genome expressed in each
activity, which serves as a measure of transfer of the cell line is indicated above each lane. The position of genomic RNA
vector. No alkaline phosphatase-expressing cells were (8 kb) is indicated. (A) Total RNA from cells. Each lane contains 5
mg total RNA. (B) Viral RNA from virus pellets. For virus particles, theobserved in the infections using up to 1 ml virus from
amount of cell-free supernatant used to prepare virus pellets for RNAthe D17-61E-DC cell line. Parallel experiments with the
extraction is denoted above the lane. Lanes 4 and 6 contain viral RNA
61E positive control suggest that this assay is sensitive from 10 or 1 ml of a 1:10 dilution of culture supernatant (i.e., 1 ml of
to the level of approximately 5 infectious particles per viral supernatant in 9 ml of fresh medium), respectively. Lane 7 contains
10 ml of a 1:100 dilution of culture supernatant.milliliter (Fig. 4). Thus, results of the marker rescue assay
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mutagenesis experiments demonstrated that a specific
RNA secondary structure in this region is required for
efficient packaging of SNV RNAs (Yang and Temin, 1994).
In addition, an 80-nt region containing the double hairpin
structures from MoMuLV/MuSV could be substituted for
the 80-nt double hairpin structure from SNV in a SNV
retroviral vector without significantly decreasing the effi-
ciency of RNA packaging. These experiments suggest
that some features of the overall structure of the packag-
ing signal have been conserved among distantly related
type C retroviruses. In addition to the requirement for
double hairpins, it appears that some specific sequences
are also important (Yang and Temin, 1994), and these
have been conserved in many type C retroviruses as
well. In the experiments described here, we have deleted
FIG. 4. Marker rescue assay. Feline T cells harboring the murine a region of the FeLV leader that encompasses all of the
retroviral vector LAPSN were infected with 61E or 61E-DC virus. The
first hairpin and half of the stem of the second hairpin61E virus titer is denoted as infectious particles (IP), which was deter-
(Fig. 1B), which would be predicted to prevent eithermined as the TCID50 measured by endpoint dilution of feline T cells.
After 3 weeks, virus supernatant was harvested from infected T cells hairpin from forming. Although the core regions of MuLV
and used for infection of feline fibroblasts. Fibroblasts were stained C and FeLV C appear to be located between the SD and
for alkaline phosphatase (AP) activity 2 days postinfection. Feline fibro- gag initiation codon, this noncoding region is longer for
blasts expressing AP are shaded in black, and those that do not ex-
MuLV. Nonetheless FeLV can efficiently package MuLVpress AP activity are not shaded. The number of RT equivalents present
vectors, which allows development of packaging cellin the virus supernatants used for infection of T cells was determined
by phosphoimaging analysis of RT reactions. lines using MuLV reagents.
The packaging line described in this study expresses
a subgroup A FeLV envelope protein, which has an eco-
able to perform all the functions required for a single
tropic host range. The other FeLV subgroups, B and C,
round of infection and that the feline viral proteins can
have a broader host range that includes several mamma-
efficiently package the murine vector. No infectious virus
lian species, including cat, dog, and human cell lines
was detected in D17-61E-DC/LAPSN cells using the
(Jarrett et al., 1973; Sarma et al., 1975). Using the 5* 61E-
marker rescue assay, which suggested that no helper
DC construct described here, construction of packaging
viruses were generated by recombination between the
lines expressing subgroup B and C envelope genes is
FeLV proviral DNA and the MuLV retroviral vector (data
currently underway. Such packaging cell lines will be
not shown).
useful for receptor cloning studies and analyses of the
determinants for specific FeLV envelope/receptor inter-
DISCUSSION
actions.
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